STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Keros Therapeutics, Inc.
KROS
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.09
+1749.2%
Net Income/Share
$-5.00
+3.7%
Operating CF/Share
$-4.30
-1.6%
Free CF/Share
$-4.35
-0.9%
Cash/Share
$14.96
+33.0%
Book Value/Share
$15.27
+35.3%
Tangible Book/Share
$15.27
+35.3%
Equity/Share
$15.27
+35.3%
Interest Debt/Share
$0.50
+2.7%
Valuation
Market Cap
$592.64M
-49.4%
Enterprise Value
$51.57M
-94.0%
P/E Ratio
-3.16
+58.7%
P/S Ratio
166.94
-97.8%
P/OCF Ratio
-3.68
+60.8%
P/FCF Ratio
-3.64
+60.5%
P/B Ratio
1.04
-70.6%
P/TB Ratio
1.04
-70.6%
EV/Sales
14.53
-99.7%
EV/EBITDA
-0.28
+95.1%
Profitability
Earnings Yield
-31.61%
-141.9%
FCF Yield
-27.47%
-153.3%
ROE
-32.78%
+28.8%
ROIC
-35.71%
+27.2%
Return on Tangible Assets
-30.42%
+26.4%
Capital Allocation
CapEx/OCF
-1.20%
+39.3%
CapEx/Revenue
54.39%
-96.7%
CapEx/Depreciation
1.57
-48.0%
SBC/Revenue
982.31%
-94.8%
Balance Sheet
Debt/Equity
0.03
-24.1%
Debt/Assets
0.03
-21.5%
Net Debt/EBITDA
2.91
+39.9%
Current Ratio
21.45
+50.6%
Interest Coverage
0.00x
Income Quality
0.86
+5.5%
Efficiency
Days Sales Outstanding
458 days
-82.6%
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.80x
+475.6%
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$13.86
+38.8%